Celebrating a major milestone for UCSF Center for Research in Transfusion Medicine and Cell Therapies! Congratulations to our multidisciplinary CTMCT team, who are part of a $10 million grant from the United States Department of Defense (DOD) awarded through the MTEC | Medical Technology Enterprise Consortium and the Armed Forces Institute of Regenerative Medicine (AFIRM). The grant will focus on conducting a multicenter trial investigating the therapeutic potential of adipose tissue mesenchymal stromal/stem cells (MSCs) in Stage 2 acute kidney injury (AKI) induced by trauma and burns. The grant is entitled “Allogenic adipose-derived mesenchymal stromal cells (MSC) for acute kidney injury after trauma or burn.”
UCSF is excited to be one of the 3 sites which includes UT Houston and the University of Alabama. We are thrilled to collaborate with esteemed experts and partners; Drs. Charles Cox, MD Professor at UT Houston, who is the lead PI, John Holcomb Professor at UAB, Dr. Sabrina Goddard from UAB, and Donna Chang, CEO of Hope Biosciences.
Team members:
Charles Cox, Donna Chang, Lucy Zumwinkle Kornblith, Shibani Pati, Joseph Cuschieri, Andrew Leavitt, John Holcomb, Sabrina Goddard, Erin Fox, Kathleen Liu
